RE:RE:RE:RE:RE:whoops... $82 mio EBITDA in Q1..All analysts expected 0.70+/ share cash from the settlement except Raymond James. RayJay was spot on at 0.41/share.
Cannacord has a $2.75 target with 80M cash infusion. Based on this, they have to cut the target to 2.50.